Broncus Company Description
Bucking bronchial conditions is what Broncus Technologies is all about. The company develops medical devices known as bronchoscopic interventions that treat chronic lung diseases. Its Exhale treatment system targets patients with emphysema and is in clinical trial stages. The system includes the Exhale Drug-Eluting Stent and related implements used in the company's patented Airway Bypass procedure for collapsed airways. The Exhale stent uses a drug-eluting technology licensed from Angiotech. Other disease targets include lung cancer, pulmonary hypertension, and chronic bronchitis.
View the Comprehensive Company Description for Broncus
The Company Description provides a historical perspective of Broncus's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Broncus's evolution in the marketplace.
